Carac (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Carac drug offered from Valeant Pharmaceuticals North America LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | fluorouracil |
SUBSTANCE NAME: | FLUOROURACIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-06-28 |
END MARKETING DATE: | 0000-00-00 |
Carac HUMAN PRESCRIPTION DRUG Details:
Item Description | Carac from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/g) |
START MARKETING DATE: | 2013-06-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-5200_fc805fee-4a6a-4807-91cc-dc450887cb37 |
PRODUCT NDC: | 0187-5200 |
APPLICATION NUMBER: | NDA020985 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers: